| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |